50,163 Shares in Omada Health, Inc. $OMDA Purchased by WINTON GROUP Ltd

WINTON GROUP Ltd bought a new position in shares of Omada Health, Inc. (NASDAQ:OMDA) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 50,163 shares of the company’s stock, valued at approximately $1,101,000.

Several other large investors have also modified their holdings of OMDA. Quarry LP purchased a new stake in shares of Omada Health in the 4th quarter worth approximately $29,000. Raymond James Financial Inc. bought a new position in Omada Health in the second quarter worth approximately $32,000. Integrated Wealth Concepts LLC bought a new position in Omada Health in the second quarter worth approximately $53,000. Versant Capital Management Inc lifted its holdings in Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after buying an additional 2,283 shares during the period. Finally, New York State Common Retirement Fund bought a new stake in Omada Health during the 4th quarter valued at $73,000.

Omada Health Price Performance

Shares of OMDA stock opened at $19.66 on Monday. The stock’s fifty day moving average price is $22.63 and its 200 day moving average price is $17.97. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $26.92. The company has a market cap of $1.20 billion, a price-to-earnings ratio of 393.20 and a beta of 1.86.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The business had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. As a group, equities research analysts anticipate that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on OMDA. JPMorgan Chase & Co. boosted their price target on Omada Health from $26.00 to $30.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Canaccord Genuity Group lifted their target price on Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a research note on Tuesday, July 21st. Citizens Jmp increased their price target on shares of Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research report on Friday, August 14th. Citigroup restated an “outperform” rating on shares of Omada Health in a report on Friday, August 14th. Finally, Barclays boosted their price objective on shares of Omada Health from $25.00 to $27.00 and gave the stock an “overweight” rating in a research note on Friday. Eleven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.67.

Key Stories Impacting Omada Health

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Analyst support remains strong: BTIG Research reaffirmed its “buy” rating and set a $35 price target, while Needham & Company also maintained a “buy” rating with a $28 target. These targets imply significant potential upside and reinforce confidence in Omada’s growth outlook.
• Positive Sentiment: Investor Day could provide new growth targets: Omada held its inaugural Investor Day and planned to present updated long-term financial targets. More ambitious revenue, profitability, or membership goals could improve investor confidence if management’s outlook exceeds current expectations. Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
• Neutral Sentiment: Investor Day transcript available: The transcript may offer additional detail on Omada’s strategy and financial targets, but the supplied report does not identify specific changes that would immediately alter earnings expectations. Omada Health Analyst/Investor Day Transcript
• Negative Sentiment: Chief accounting officer sold shares: CAO Craig Gracey sold 644 shares for approximately $14,000, reducing his direct ownership by 4.28%. The relatively small transaction is not necessarily a sign of deteriorating fundamentals, but insider selling can create short-term negative sentiment. SEC Insider Transaction Filing

Insider Activity at Omada Health

In other news, CEO Sean P. Duffy sold 21,572 shares of the business’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $23.62, for a total transaction of $509,530.64. Following the sale, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at $9,728,156.82. The trade was a 4.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Craig Gracey sold 1,042 shares of the company’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $25.00, for a total value of $26,050.00. Following the completion of the transaction, the chief accounting officer directly owned 15,441 shares in the company, valued at approximately $386,025. The trade was a 6.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 259,767 shares of company stock worth $5,605,349 in the last quarter. 6.38% of the stock is currently owned by company insiders.

Omada Health Profile

Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.

The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.

Omada primarily serves members through employers, health plans and healthcare organizations in the United States.